Research & Development: Page 39
-
PharmaVoice Team/PharmaVoice
The Role of AI in Helping Clinicians Diagnose Patients
I once thought I had multiple sclerosis. Actually, I may still have multiple sclerosis. I really don’t know for sure. A few months ago, a series of MS disease-awareness pop-ups began showing up on my web browser. They captured my attention because for a while I’d been experiencing a mix of health...
By Susan Abedi • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Staying Ahead of the AI Curve in Commercial Pharma
The commercial model within life sciences is ripe for change. In a landscape with harder to reach healthcare providers (HCPs) who are faced with more marketing noise than ever, the need for improved engagement is significant. According to DRG Digital, only 12% of HCPs said they had emailed with t...
By Matthew Van Wingerden • Oct. 1, 2019 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
The Role Artificial Intelligence Plays in Humanizing the Health Experience
It used to be a broad, one-size-fits-all remedy for common complaints. If you needed it, there was little choice in what kind you received. If you didn’t need it, someone was ready to convince you otherwise. Fine-tuning it for an individual need was so cost-prohibitive the idea was basically scie...
By David Geisinger • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Transforming Clinical Development with AI
Applications in Imaging and Performance Risk Management The pharmaceutical industry and regulators alike have acknowledged for some time that the clinical development process is in need of an overhaul. Companies must find a way to innovate more efficiently to meet market demands and remain compet...
By Chris Porter • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
AI and Healthcare: From Potential to Powerful Solutions
In recent years, healthcare and pharma companies have been increasingly investing in the promise of artificial intelligence (AI), machine learning (ML), and other smart technologies. It’s estimated that the global market for AI healthcare will grow to as much as $27.6 billion by 2025.1 This growt...
By Dr. Harietta Eleftherochorinou • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Microbes As Therapies
While microbiome research is still in its infancy, interest and investment in this field of research has grown quickly. Efforts are ongoing to study how changes in the human microbiome can impact our health. Trillions of microbes — including bacteria, fungi, and viruses — call us home. These bact...
By Denise Myshko • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
The Blockchain Movement
The pharmaceutical industry is actively exploring blockchain technology — a digital ledger system for records and log transactions — for a number of uses. Experts discuss applications for the industry. Blockchain, the underlying technology behind bitcoin and other cryptocurrencies, is being explo...
By Denise Myshko • Oct. 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
The Intersection of Physics and Biology Daniel O’Connor, President and CEO of OncoSec, talks about his company’s efforts to develop new technologies to stimulate the body’s immune system to target and attack cancer. It is estimated that there are 1.6 million new cases of solid tumor cancers in th...
By Daniel O'Connor • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
New Microscope Reveals Interactions Between Drugs and Receptors Trend Watch: Advances in Healthtech Benefit Oncology, Military Docs, Patients, Drug Delivery, and More Researchers at Case Western Reserve University School of Medicine have used a cryo-electron microscopy technique to observe the in...
By PharmaVoice Team • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
Using AI to Connect Patients To Clinical Trials Trend Watch: AI Advances: From Nutrition Advice to Digital Pathology Ohio-based Deep Lens has developed an AI-enabled digital pathology platform that connects to trusted networks of pharma sponsors, researchers, and care teams, so patients can be ma...
By PharmaVoice Team • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Last Word
Improving Clinical Trials Through Conversations Suzann Johnson, Associate Director of Investigator and Patient Engagement at Janssen, talks about how the company’s HealthCaring Conversations for Clinical Research initiative can improve the clinical trial experience for patients and investigators....
By Suzann Johnson • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
SHOWCASE: Big Data: Realizing Big Impacts from Investing in Big Data
The pharmaceutical industry is investing more and more in big data to transform different parts of the business and bolster pipelines. Investment in big data is expected to grow to $7 billion by the end of 2021, up from $4.7 billion in 2018, comprising spending on hardware, software, and professi...
By PharmaVoice Team • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Why Patients Avoid Clinical Trials
And how big data, analytics, technology and domain expertise can help change the paradigm The pharma industry has a big challenge when it comes to clinical trials, one that continues to hinder the industry’s approach to research. Sponsors want patients to enroll in their trials, but the clinical ...
By Cynthia Verst • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
A Framework for Harnessing Big Data in Creative Ideation
We propose a five-part framework for marketers and advertisers looking to harness the potential of data and creativity in healthcare communications in this era of big data and artificial intelligence. Data and Creativity Big data and its related components, such as AI and deep learning, are big t...
By Iyiola Obayomi • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
No Longer Lost in Translation
Biopharma companies, academia, patient groups, and the NIH are embracing translational medicine to increase the number of drugs that can be successfully brought to market. The current process of translating a new discovery into a therapy is slow and expensive. The average length of time from disc...
By Denise Myshko • Sept. 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Imagine if… When we introduced the PharmaVOICE 100 most inspiring people in the life-sciences industry 15 years ago it began a movement. We sought to capture that intangible measure of a person’s influence: inspiration. And we thought who better to identify these individuals than you, our readers...
By Taren Grom • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
PharmaVOICE 100 Who's on the List - By Category
Who’s on the List — 2019 Indexed by Category Commanders & Chiefs Paul Balagot precisioneffect Percival Barretto-Ko Astellas US Udit Batra MilliporeSigma Dan Bradbury Equillium Dr. Pablo Cagnoni Rubius Therapeutics Sharon Callahan TBWA\WorldHealth Dr. Donald Deieso WIRB-Copernicus Group Drew D...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Clinical Experts
These clinical development experts are redefining clinical operations to increase efficiencies, reduce costs and timelines, and improve the safety profiles of bringing new medicines to patients. A Rare Passion for Patients Energetic. Unrelenting. L. Mary Smith, Ph.D. Title: Senior VP, Clinical R&...
By PharmaVoice Team • Aug. 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Trending Now… As we head into the second half of the year (as hard to believe as that is) this is a great time to hit pause and evaluate what’s coming down the pike. In this issue, in particular, we are looking at a couple of areas that will have a lasting impact on the industry. First, this mont...
By Taren Grom • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Upfront
Merck Debuts Documentary A Touch of Sugar Merck’s documentary film, A Touch of Sugar, debuted during the Tribeca Film Festival in April as a part of the company’s America’s Diabetes Challenge: Get to Your Goals. Narrated by award-winning actress and documentary spokesperson Viola Davis, the film ...
By PharmaVoice Team • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Colon Cancer Screening without the Prep Alex Ovadia, CEO of Check-Cap, talks about the company’s ingestible imaging capsule-based system for colorectal cancer screening. Colorectal cancer (CRC) — the term referring to both rectal and colon cancers — is the third most common cancer diagnosed in bo...
By Alex Ovadia • June 1, 2019 -
PharmaVoice Team/PharmaVoice
HealthTech
A Mobile Game That Can Detect Alzheimer’s Risk Trend Watch: From Games to Wrist Bands to at Home Diagnostic Tests, Healthtech Applications Expand Personalized Treatment or Therapy A specially designed mobile phone game can detect people at risk of Alzheimer’s, according to research from the Univ...
By PharmaVoice Team • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Artificial Intelligence
IBM to use ML and AI to Diagnose Alzheimer’s Trend Watch: From drug development to diagnoses, pharma uses AI across the spectrum IBM has discontinued the development and sales of its Watson for drug discovery product due to poor financial performance, however, it will continue to serve pharmaceut...
By PharmaVoice Team • June 1, 2019 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Inspiring Leaders For the past 15 years or so, PharmaVOICE has had the honor of showcasing the Healthcare Businesswomen’s Association’s Rising Stars and more recently the Luminaries as well. These women have been identified by their organizations — which span the breadth of the healthcare ecosyst...
By Taren Grom • May 1, 2019 -
PharmaVoice Team/PharmaVoice
Innovator's Corner
Plants as Anti-infectives Alexander Huang, President and Chairman of Quellthera, talks about the company’s research on biomimicry of plant immune processes as potential therapeutics for hard-to-treat infections. Infections caused by antibiotic-resistant germs are difficult, and may soon become im...
By Alexander Huang • May 1, 2019
Previous
